| Jun 14, 2023 |
Jun 15, 2023 |
Insight Molecular Diagnostics Inc.
|
Director |
Buy |
85.0
|
+30,000
|
5.63%
|
✗
|
$6.4K |
| Dec 22, 2022 |
Dec 27, 2022 |
Insight Molecular Diagnostics Inc.
|
Director |
Buy |
82.5
|
+25,000
|
4.92%
|
✗
|
$7.1K |
| Aug 15, 2022 |
Aug 17, 2022 |
Insight Molecular Diagnostics Inc.
|
Director |
Buy |
82.5
|
+20,000
|
4.10%
|
✗
|
$9.7K |
| Dec 23, 2020 |
Dec 28, 2020 |
Insight Molecular Diagnostics Inc.
|
Director |
Sell |
45.0
|
-900
|
-0.22%
|
✗
|
$2.3K |
| Dec 21, 2020 |
Dec 23, 2020 |
Insight Molecular Diagnostics Inc.
|
Director |
Sell |
26.3
|
-42,800
|
-3.92%
|
✗
|
$13.1K |
| Aug 17, 2017 |
Aug 21, 2017 |
Lineage Cell Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-300,000
|
-4.11%
|
✗
|
$843K |
| Jul 31, 2017 |
Aug 2, 2017 |
Lineage Cell Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-150,000
|
-2.01%
|
✗
|
$420K |
| Jan 20, 2016 |
Jan 22, 2016 |
Lineage Cell Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-300,000
|
-3.84%
|
✗
|
$705K |
| Nov 6, 2015 |
Nov 10, 2015 |
Lineage Cell Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-100,000
|
-1.26%
|
✗
|
$383K |
| May 16, 2014 |
May 16, 2014 |
Lineage Cell Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-300,000
|
-3.62%
|
✗
|
$735K |
| May 8, 2014 |
May 9, 2014 |
Lineage Cell Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-300,000
|
-3.49%
|
✗
|
$730.5K |
| Mar 28, 2013 |
Mar 29, 2013 |
Lineage Cell Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-200,000
|
-2.14%
|
✗
|
$762K |
| Dec 14, 2012 |
Dec 18, 2012 |
Lineage Cell Therapeutics, Inc.
|
Officer |
Sell |
32.5
|
-57,511
|
-0.60%
|
✗
|
$249.4K |
| Nov 15, 2012 |
Nov 19, 2012 |
Lineage Cell Therapeutics, Inc.
|
Officer |
Sell |
17.5
|
-344,828
|
-3.46%
|
✗
|
$1M |
| Jul 30, 2012 |
Jul 31, 2012 |
Lineage Cell Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-140,000
|
-1.38%
|
✗
|
$667.3K |